BillionToOne, Inc. Class A Common Stock vs. Caris Life Sciences, Inc. Common Stock
BLLN
BillionToOne, Inc. Class A Common Stock
$91.65 -38.89%
VS CAICaris Life Sciences, Inc. Common Stock
$20.00 +21.58%
BillionToOne, Inc. Class A Common Stock (BLLN) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| BLLN | CAI | |
|---|---|---|
| Market Cap | $4.32 billion | $5.65 billion |
| Revenue (TTM) | $397.41 million | $907.29 million |
| Net Income (TTM) | $37.71 million | $33.98 million |
CAI leads on 2 of 3 size & scale factors.
Valuation
| BLLN | CAI | |
|---|---|---|
| P/E Ratio | 88.98 | — |
| Price / Book | 8.06 | 9.52 |
| Price / Sales | 10.88 | 6.23 |
BLLN and CAI split the valuation factors evenly.
Profitability
| BLLN | CAI | |
|---|---|---|
| Net Margin | 9.49% | 3.75% |
| Return on Equity | 7.03% | 5.73% |
BLLN leads on 2 of 2 profitability factors.
Dividend
| BLLN | CAI | |
|---|---|---|
| Dividend Yield | — | 6.00% |
BLLN and CAI split the dividend factors evenly.
Risk & Sentiment
| BLLN | CAI | |
|---|---|---|
| Short Interest | 0.13% | 0.13% |
BLLN leads on 1 of 1 risk & sentiment factors.
Dig deeper: BLLN overview, BLLN financials, CAI overview, CAI financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.